 James Lavelle
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 3 | 2020 | 373 | 0.330 |
Why?
| | Dexmedetomidine | 2 | 2014 | 47 | 0.200 |
Why?
| | Hypnotics and Sedatives | 2 | 2014 | 222 | 0.170 |
Why?
| | Hexosaminidases | 1 | 2019 | 17 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 478 | 0.120 |
Why?
| | Up-Regulation | 1 | 2019 | 848 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 100 | 0.110 |
Why?
| | Lorazepam | 1 | 2014 | 26 | 0.100 |
Why?
| | HIV Infections | 2 | 2020 | 3195 | 0.100 |
Why?
| | Midazolam | 1 | 2013 | 73 | 0.100 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 420 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2015 | 307 | 0.090 |
Why?
| | Lipopolysaccharides | 1 | 2015 | 858 | 0.090 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2014 | 185 | 0.090 |
Why?
| | Mental Recall | 1 | 2013 | 223 | 0.090 |
Why?
| | Anticonvulsants | 1 | 2014 | 246 | 0.090 |
Why?
| | Inflammation | 2 | 2020 | 2884 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 920 | 0.080 |
Why?
| | Ethanol | 1 | 2014 | 631 | 0.070 |
Why?
| | Smokers | 2 | 2020 | 138 | 0.070 |
Why?
| | Critical Care | 1 | 2013 | 702 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 638 | 0.060 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2004 | 139 | 0.050 |
Why?
| | Catheterization | 1 | 2003 | 184 | 0.050 |
Why?
| | Catheterization, Central Venous | 1 | 2003 | 123 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2004 | 356 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2004 | 443 | 0.040 |
Why?
| | Bacteremia | 1 | 2003 | 222 | 0.040 |
Why?
| | Cross Infection | 1 | 2003 | 260 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 322 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 2064 | 0.040 |
Why?
| | Intensive Care Units | 2 | 2014 | 924 | 0.030 |
Why?
| | Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 2015 | 4 | 0.030 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2015 | 8 | 0.030 |
Why?
| | Capillary Leak Syndrome | 1 | 2015 | 12 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 247 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 207 | 0.030 |
Why?
| | Middle Aged | 4 | 2020 | 36309 | 0.030 |
Why?
| | Stress Disorders, Traumatic, Acute | 1 | 2013 | 7 | 0.030 |
Why?
| | Adult | 4 | 2020 | 40881 | 0.020 |
Why?
| | Smoking | 1 | 2020 | 1477 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 428 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 428 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2069 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1368 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1043 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.020 |
Why?
| | Male | 5 | 2020 | 73010 | 0.020 |
Why?
| | Pilot Projects | 1 | 2013 | 1898 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4302 | 0.020 |
Why?
| | Lung | 1 | 2020 | 4116 | 0.020 |
Why?
| | Female | 4 | 2020 | 79045 | 0.020 |
Why?
| | Anxiety | 1 | 2013 | 1122 | 0.010 |
Why?
| | Humans | 5 | 2020 | 145783 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5992 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2004 | 69 | 0.010 |
Why?
| | Ventricular Fibrillation | 1 | 2004 | 64 | 0.010 |
Why?
| | Electrophysiology | 1 | 2004 | 218 | 0.010 |
Why?
| | Depression | 1 | 2013 | 1559 | 0.010 |
Why?
| | Equipment Safety | 1 | 2003 | 38 | 0.010 |
Why?
| | Equipment Contamination | 1 | 2003 | 67 | 0.010 |
Why?
| | Rabbits | 1 | 2004 | 653 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2003 | 330 | 0.010 |
Why?
| | Probability | 1 | 2003 | 308 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2004 | 1049 | 0.010 |
Why?
| | Myocardial Ischemia | 1 | 2004 | 285 | 0.010 |
Why?
| | Young Adult | 1 | 2019 | 14254 | 0.010 |
Why?
| | Equipment Design | 1 | 2003 | 525 | 0.010 |
Why?
| | Prospective Studies | 1 | 2014 | 8078 | 0.010 |
Why?
| | Acute Disease | 1 | 2004 | 1036 | 0.010 |
Why?
| | Action Potentials | 1 | 2004 | 502 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2004 | 544 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 2004 | 860 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 1083 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 6085 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2004 | 756 | 0.010 |
Why?
| | Animals | 2 | 2015 | 38101 | 0.010 |
Why?
| | Mice | 1 | 2015 | 18355 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 1782 | 0.010 |
Why?
| | Incidence | 1 | 2003 | 2934 | 0.010 |
Why?
| | Risk Assessment | 1 | 2003 | 3752 | 0.010 |
Why?
| | Aged | 1 | 2013 | 26217 | 0.010 |
Why?
|
|
Lavelle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|